China Universal Asset Management Co., Ltd. Avidity Biosciences, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 24,113 shares of RNA stock, worth $858,181. This represents 0.07% of its overall portfolio holdings.
Number of Shares
24,113
Previous 25,298
4.68%
Holding current value
$858,181
Previous $735,000
3.27%
% of portfolio
0.07%
Previous 0.07%
Shares
16 transactions
Others Institutions Holding RNA
# of Institutions
244Shares Held
116MCall Options Held
289KPut Options Held
998K-
Janus Henderson Group PLC London, X011.4MShares$407 Million0.19% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.3MShares$404 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA9.68MShares$345 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.24MShares$329 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.75MShares$311 Million4.23% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.86B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...